Pharma Focus Asia

Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

Coeptis Therapeutics Enters into Sponsored Research Agreement with the University of Pittsburgh to Advance SNAP-CAR Development Program

Tuesday, January 31, 2023

Coeptis Therapeutics Holdings Inc a biopharmaceutical company developing innovative cell therapy platforms for cancer today announced a sponsored research agreement with the University of Pittsburgh to advance preclinical development of SNAPCAR T cel...

BenchSci Announces Launch of ASCEND™ – a First-of-its-Kind ‘Map’ of All Disease Biology that Aims to Transform Pharmaceutical Research

Tuesday, January 31, 2023

BenchSci a world leader in AI solutions for drug discovery today announced the launch of its latest technology ASCEND by BenchSci helping remove barriers that result in percent of pharmaceutical research investment that fails to reach patients The i...

INOVIO Announces Strategic Reorganization, Continues Efforts to Focus on Promising DNA Medicine Candidates

Tuesday, January 31, 2023

INOVIO a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPVassociated diseases cancer and infectious diseases today announced a strategic reorganization that is intended to deliver...

Reneo Pharmaceuticals Receives Fast Track Designation from the FDA for Mavodelpar (REN001) in a Genotype of Long-Chain Fatty Acid Oxidation Disorder (LC-FAOD)

Tuesday, January 31, 2023

Reneo Pharmaceuticals Inc a clinicalstage pharmaceutical company focused on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases today announced that the US Food and Drug Administration FDA has gran...

Sciwind Biosciences Announces Initiation of Patient Dosing in Phase 3 Clinical Trials of Ecnoglutide (XW003), a Long-acting GLP-1 analog, for the Treatment of Type 2 Diabetes in China

Tuesday, January 31, 2023

Sciwind Biosciences Co Ltd a clinicalstage biopharmaceutical company focused on discovering and developing innovative therapies to treat metabolic disease announced today the initiation of patient dosing in Phase clinical trials of ecnoglutide XW in...

Daewoong enters exclusive licensing agreement with CS Pharmaceuticals for Bersiporocin in Idiopathic Pulmonary Fibrosis in the Greater China Region

Tuesday, January 31, 2023

Daewoong PharmaceuticalCEO Sengho Jeon and Changjae Lee has secured an exclusive licensing agreement with CS Pharmaceuticals CSP a UK based multinational company focused on the development and commercialization of rare disease and ophthalmology produ...

Nanoscope Therapeutics Receives Fast Track Designation by the FDA for MCO-010 for the Treatment of Stargardt Disease

Monday, January 30, 2023

Nanoscope Therapeutics Inc a clinicalstage biotechnology company developing gene therapies for retinal degenerative diseases today announced that the US Food and Drug Administration FDA has granted Fast Track Designation FTD to MCO an ambientlight ac...

Ribon Therapeutics Announces $25 Million Equity Investment from Pfizer

Monday, January 30, 2023

Ribon Therapeutics a clinicalstage biotechnology company developing therapeutics to target stress support pathways today announced a million investment from Pfizer Ribon plans to use the proceeds to support clinical development of its potentially fi...

GeneDx Makes Significant Industry-Wide Contributions to New Disease Gene Discovery

Monday, January 30, 2023

Throughout GeneDx a leader in delivering improved health outcomes through genomic and clinical insights contributed a significant amount of total candidate gene submissions to GeneMatcher a platform that facilitates new disease gene discovery and...

Lecanemab Receives Priority Review Status In Japan

Monday, January 30, 2023

Eisai Co Ltd and Biogen Inc announced today that an application for manufacturing and marketing approval for lecanemab generic name US brand name LEQEMBI an antiamyloid A protofibril antibody in Japan has been designated for Priority Review by the Ja...